Biomimetic oxidation studies of monensin A catalyzed by metalloporphyrins: Identification of hydroxyl derivative product by electrospray tandem mass spectrometry

Monensin A is an important commercially available natural product isolated from Streptomyces cinnamonensins that shows antibiotic and anti-parasitic activities. This molecule has a significant influence in the antibiotic market, but until now there are no studies on putative metabolite formations. Bioorganic catalysts applying metalloporphyrins and mono-oxygen donors are able to mimic the cytochrome P450 reactions. This model has been employed for natural product metabolism studies affording several new putative metabolites and in vivo experiments confirming the relevance of this procedure. In this work we evaluated the potential of 10,15,20-tetrakis (pentafluorophenyl) porphyrin metal(III) chloride [Fe(TFPP)Cl] catalyst models to afford a putative monensin A metabolite. Oxidation agents such as meta-chloroperoxy benzoic acid, iodosylbenzene, hydrogen peroxide 30 wt.% and tert-butyl hydroperoxide 70 wt.%, were used to investigate different reaction conditions, in addition to the analysis of the influence of the solvent. The quantification of total monensin A conversion and the structure of the new hydroxylated putative metabolite were proposed based on electrospray ionization tandem mass spectrometry analysis. The porphyrin tested, afforded moderate conversions of monensin A in all reaction conditions and the selectivity was found to be dependent on the oxidation/medium employed.

[1]  Adam Huczyński.  Polyether Ionophores‐Promising Bioactive Molecules for Cancer Therapy , 2013 .

[2]  Adam Huczyński,et al.  Structure and Antimicrobial Properties of Monensin A and Its Derivatives: Summary of the Achievements , 2013, BioMed research international.

[3]  H. Humpf,et al.  In vitro Metabolism of Grandisin, a Lignan with Anti-chagasic Activity , 2012, Planta Medica.

[4]  N. Lopes,et al.  Biomimetic in vitro oxidation of lapachol: a model to predict and analyse the in vivo phase I metabolism of bioactive compounds. , 2012, European journal of medicinal chemistry.

[5]  M. D. Assis,et al.  Carbamazepine oxidation catalyzed by manganese porphyrins: Effects of the β-bromination of the macrocycle and the choice of oxidant , 2011 .

[6]  E. Crevelin,et al.  Biomimetic simazine oxidation catalyzed by metalloporphyrins , 2011 .

[7]  M. D. Vargas,et al.  Novel biomimetic oxidation of lapachol with H2O2 catalysed by a manganese(iii) porphyrin complex , 2011 .

[8]  D. Mansuy,et al.  Brief historical overview and recent progress on cytochromes P450: adaptation of aerobic organisms to their chemical environment and new mechanisms of prodrug bioactivation. , 2011, Annales pharmaceutiques francaises.

[9]  N. Lopes,et al.  Biomimetic oxidation of piperine and piplartine catalyzed by iron(III) and manganese(III) porphyrins. , 2010, Biological & pharmaceutical bulletin.

[10]  M. D. Assis,et al.  Primidone oxidation catalyzed by metalloporphyrins and Jacobsen catalyst , 2008 .

[11]  U. Karst,et al.  Biomimetic modeling of oxidative drug metabolism , 2008, Analytical and bioanalytical chemistry.

[12]  M. D. Assis,et al.  Carbamazepine oxidation catalyzed by iron and manganese porphyrins supported on aminofunctionalized matrices , 2008 .

[13]  M. Holčapek,et al.  High-performance liquid chromatography–tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites , 2008, Analytical and bioanalytical chemistry.

[14]  N. Lopes,et al.  HPLC-ESI-MS/MS analysis of oxidized di-caffeoylquinic acids generated by metalloporphyrin-catalyzed reactions , 2008 .

[15]  M. Schiavon,et al.  Jacobsen catalyst as a P450 biomimetic model for the oxidation of an antiepileptic drug , 2007 .

[16]  J. Smith,et al.  Oxidation of alkanes by iodosylbenzene (PhIO) catalysed by supported Mn(III) porphyrins : Activity and mechanism , 2006 .

[17]  B. Bahramian,et al.  Manganese (III) salen immobilized on montmorillonite as biomimetic alkene epoxidation and alkane hydroxylation catalyst with sodium periodate , 2006 .

[18]  N. Lopes,et al.  Oxidative metabolism of 5-o-caffeoylquinic acid (chlorogenic acid), a bioactive natural product, by metalloporphyrin and rat liver mitochondria. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  Sason Shaik,et al.  Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. , 2004, Chemical reviews.

[20]  J. Staunton,et al.  Fragmentation studies on tetronasin by accurate-mass electrospray tandem mass spectrometry , 2004, Journal of the American Society for Mass Spectrometry.

[21]  B. Meunier,et al.  Biomimetic Chemical Catalysts in the Oxidative Activation of Drugs , 2004 .

[22]  J. Klinowski,et al.  Sodium monensin dihydrate , 2003 .

[23]  J. Staunton,et al.  Fragmentation studies on lasalocid acid by accurate mass electrospray mass spectrometry. , 2002, The Analyst.

[24]  J. Staunton,et al.  Fragmentation studies on monensin A by sequential electrospray mass spectrometry. , 2002, The Analyst.

[25]  Hui Hong,et al.  Fragmentation studies on monensin A and B by accurate-mass electrospray tandem mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[26]  J. Rosén.  Efficient and sensitive screening and confirmation of residues of selected polyether ionophore antibiotics in liver and eggs by liquid chromatography-electrospray tandem mass spectrometry. , 2001, The Analyst.

[27]  Hui Hong,et al.  A Study of the Effect of pH, Solvent System, Cone Potential and the Addition of Crown Ethers on the Formation of the Monensin Protonated Parent Ion in Electrospray Mass Spectrometry , 2001 .

[28]  Craig A. Wilson,et al.  The conformations of monensin-A metal complexes in solution determined by NMR spectroscopy , 2000 .

[29]  W. Adam,et al.  Metal-Oxo and Metal-Peroxo Species in Catalytic Oxidations , 2000 .

[30]  M. Dacasto,et al.  Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[31]  R. Julian,et al.  Electrospray ionization mass spectrometry with in-source collision-induced dissociation of monensin factors and related metabolites , 1998 .

[32]  C. A. Russell,et al.  The characterisation of polyether ionophore veterinary drugs by HPLC-electrospray MS. , 1998, The Analyst.

[33]  C. Elliott,et al.  Critical Review. Methods for the detection of polyether ionophore residues in poultry , 1998 .

[34]  J. Groves,et al.  Detection and Characterization of an Oxomanganese(V) Porphyrin Complex by Rapid-Mixing Stopped-Flow Spectrophotometry , 1997 .

[35]  D. Kennedy,et al.  Determination of monensin, salinomycin and narasin in muscle, liver and eggs from domestic fowl using liquid chromatography-electrospray mass spectrometry. , 1996, Journal of chromatography. B, Biomedical applications.

[36]  W. Pryor.  Cytochrome P450: Structure, mechanism, and biochemistry , 1996 .

[37]  Ortiz de Montellano,et al.  Cytochrome P-450: Structure, Mechanism, and Biochemistry , 1986 .

[38]  K. Davison.  Monensin absorption and metabolism in calves and chickens , 1984 .

[39]  W. Duax,et al.  Complexation of metal ions by monensin. Crystal and molecular structure of hydrated and anhydrous crystal forms of sodium monensin , 1980 .

[40]  J. Manthey,et al.  Metabolism of monensin in the steer and rat. , 1978, Journal of agricultural and food chemistry.

[41]  F. Kampas,et al.  On the preparation of metalloporphyrins , 1970 .

[42]  C. A. Grob.  Mechanisms and Stereochemistry of Heterolytic Fragmentation , 1969 .

[43]  J. H. Johnson,et al.  Antibiotic-mediated transport of alkali ions across lipid barriers. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Steinrauf,et al.  The structure of monensic acid, a new biologically active compound. , 1967, Journal of the American Chemical Society.

[45]  P. Wharton,et al.  Fragmentation of 1,10-Decalindiol Monotosylates1 , 1965 .

[46]  C. Grob,et al.  Die 1,4‐Eliminierung unter Fragmentierung , 1955 .